학술논문
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Document Type
Article
Author
Louis, E.; Resche-Rigon, M.; Laharie, D.; Satsangi, J.; Ding, N.; Siegmund, B.; D'Haens, G.; Picon, L.; Bossuyt, P.; Vuitton, L.; Irving, P.; Viennot, S.; Lamb, C.A.; Pollok, R.; Baert, F.; Nachury, M.; Fumery, M.; Gilletta, C.; Almer, S.; Ben-Horin, S.; Bouhnik, Y.; Colombel, J.-F.; Hertervig, E.; Andrews, J.; Sparrow, M.; Leong, R.; Connor, S.; Radforth-Smith, G.; De Cruz, P.; Preiss, J.; Stallmach, A.; Liceni, T.; Grip, O.; Halfvarson, J.; Durai, D.; Cummings, F.; Seilinger, C.; Parkes, M.; Lindsay, J.; Lambrecht, G.; Van Hootegem, P.; Rahier, J.-F.; Dewitte, M.; Hebuterne, X.; Chanteloup, E.; Altwegg, R.; Nancey, S.; Bouguen, G.; Pineton de Chambrun, G.; Poullenot, F.; Roblin, X.
Source
In: The Lancet Gastroenterology and Hepatology . (The Lancet Gastroenterology and Hepatology, March 2023, 8(3):215-227)
Subject
Language
English
ISSN
24681253